We evaluated the influence of triple therapy and other factors like age, NEWS2, sex, body mass index, the number of coexisting disorders, pulmonary disease, antibiotics, immunosuppressive therapy, hypotension, the maximum oxygen supply, interleukin 6, C-reactive protein, and lactate dehydrogenase by a multivariable analysis. The gene discussed is CRP; the disease is lung disorder.